Evidence map›Paper›PMID 33802212›Full record

ArticleInternational journal of molecular sciences2021

Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models.

Elisa Baldelli, Mahalakshmi Subramanian, Abduljalil M Alsubaie, Guy Oldaker, Maria Emelianenko, Emna El Gazzah, Sara Baglivo, Kimberley A Hodge, Fortunato Bianconi, Vienna Ludovini and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Graph Structured Neural Networks for Perturbation Biology.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Elisa BaldelliCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0002-6288-4599
Mahalakshmi SubramanianSchool of Systems Biology, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0003-1729-7528
Abduljalil M AlsubaieSchool of Systems Biology, George Mason University, Manassas, VA 20110, USA.
Guy OldakerDepartment of Mathematical Science, George Mason University, Fairfax, VA 22030, USA.
Maria EmelianenkoDepartment of Mathematical Science, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0002-3209-4705
Emna El GazzahSchool of Systems Biology, George Mason University, Manassas, VA 20110, USA.ORCID 0000-0002-9312-4410
Sara BaglivoDivision of Medical Oncology, S. Maria della Misericordia Hospital, 06156 Perugia, Italy.
Kimberley A HodgeCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Fortunato BianconiIndependent Researcher, Belvedere 44, Montefalco, 06036 Perugia, Italy.ORCID 0000-0002-3132-0061
Vienna LudoviniDivision of Medical Oncology, S. Maria della Misericordia Hospital, 06156 Perugia, Italy.ORCID 0000-0003-2524-5824
Lucio Crino'Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 47014 Meldola, Italy.
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
Mariaelena PierobonCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA.
George Mason University · USAzienda Ospedaliera di Perugia · ITIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · IT

Funding

Associazione Italiana per la Ricerca sul Cancro 15713/2014
6 · The paper itself

Abstract

Targetable alterations in cancer offer novel opportunities to the drug discovery process. However, pre-clinical testing often requires solubilization of these drugs in cosolvents like dimethyl sulfoxide (DMSO). Using a panel of cell lines commonly used for in vitro drug screening and pre-clinical testing, we explored the DMSO off-target effects on functional signaling networks, drug targets, and downstream substrates. Eight Non-Small Cell Lung Cancer (NSCLC) cell lines were incubated with three concentrations of DMSO (0.0008%, 0.002%, and 0.004%

Indexed as

Drug Delivery SystemsA549 CellsCarcinoma, Non-Small-Cell LungDimethyl SulfoxideGene Expression RegulationHumansLung NeoplasmsNeoplasm ProteinsSignal TransductionDimethyl SulfoxideNeoplasm Proteinsdimethyl sulfoxide effectsdrug targetsNSCLC cell linespathway activationsignal transduction

Identifiers

PMID33802212
PMCPMC8001778
OpenAlexW3135413615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.